News

[NEW YORK] Goldman Sachs reported a 15 per cent rise in first-quarter profit as market volatility led to record revenue in equities trading and boosted fixed income results. The Wall Street lender ...
Dollar Tree sees near-term margin pressure from delayed tariffs. Home Depot expects growth from SRS acquisition and new tech tools. China’s new tariffs just reignited the same market patterns ...
Feb. 27Goldman Sachs, weeks after axing a diversity requirement ... equity and inclusion office, and those who worked in DEI roles have left the company, which PBS said in a memo to staff is ...
Goldman Sachs upgraded Singapore Exchange (SPXCY) to Neutral from Sell with a price target of S$13, up from S$10.80. The firm, which notes that more than 60% of Singapore Exchange’s top line is ...
Goldman Sachs rescinded their recession base case within a few hours. Right below 1 p.m., its economists wrote that they expected to change their forecast for the U.S. economy to a recession if ...
Goldman Sachs reversed its recession call on Wednesday. Analysts raised the probability of a recession for the third time before slashing their new forecast in the afternoon after President Donald ...
Goldman Sachs forecasts a lower 4.5% growth for China ... on a canal in Hangzhou in east China's Zhejiang province (Pic credit: AP) These new measures build on existing tariffs introduced ...
Goldman Sachs scraps recession call hours after Trump’s 90-day tariff pause stuns Wall Street and cools trade fears. Trump enforces 125% tariffs on China, offers 10% minimum to allies, signaling ...
Goldman Sachs economists have revised their S&P 500 targets, aligning with other Wall Street forecasters. They currently characterize the selloff as an event-driven bear market, noting its ...
Goldman Sachs has slashed its oil prices forecasts again and now expects Brent Crude to average below $60 per barrel next year, at $58, amid recession risks, slowing demand, and more supply from ...
Fintel reports that on April 8, 2025, Goldman Sachs downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to Neutral. Analyst Price Forecast Suggests 14.83% Upside As of April 1 ...